These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7938116

  • 1. Nalorphine as a stimulus in drug discrimination learning: assessment of the role of mu- and kappa-receptor subtypes.
    Smurthwaite ST, Riley AL.
    Pharmacol Biochem Behav; 1994 Jul; 48(3):635-42. PubMed ID: 7938116
    [Abstract] [Full Text] [Related]

  • 2. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ, Doty P, Negus SS, Mattox SR, Dykstra LA.
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [Abstract] [Full Text] [Related]

  • 3. Diprenorphine as a stimulus in drug discrimination learning.
    Smurthwaite ST, Riley AL.
    Pharmacol Biochem Behav; 1992 Nov; 43(3):839-46. PubMed ID: 1333085
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T, Mori T, Tsuji M, Maeda J, Kishimoto Y, Misawa M, Nagase H.
    Eur J Pharmacol; 1997 Apr 11; 324(1):21-9. PubMed ID: 9137909
    [Abstract] [Full Text] [Related]

  • 5. Buprenorphine as a stimulus in drug discrimination learning: an assessment of mu and kappa receptor activity.
    Pournaghash S, Riley AL.
    Pharmacol Biochem Behav; 1993 Nov 11; 46(3):593-604. PubMed ID: 8278436
    [Abstract] [Full Text] [Related]

  • 6. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M, Goldberg SR.
    Psychopharmacology (Berl); 2005 Jun 11; 179(4):804-12. PubMed ID: 15619107
    [Abstract] [Full Text] [Related]

  • 7. Naloxone as a stimulus in drug discrimination learning: generalization to other opiate antagonists.
    Smurthwaite ST, Kautz MA, Geter B, Riley AL.
    Pharmacol Biochem Behav; 1992 Jan 11; 41(1):43-7. PubMed ID: 1539079
    [Abstract] [Full Text] [Related]

  • 8. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ, Dykstra LA.
    J Pharmacol Exp Ther; 1989 May 11; 249(2):557-66. PubMed ID: 2566680
    [Abstract] [Full Text] [Related]

  • 9. Discriminative-stimulus effects of the low efficacy mu agonist nalbuphine.
    Walker EA, Young AM.
    J Pharmacol Exp Ther; 1993 Oct 11; 267(1):322-30. PubMed ID: 8229759
    [Abstract] [Full Text] [Related]

  • 10. Discriminative stimulus effects of spiradoline, a kappa-opioid agonist.
    Holtzman SG, Cook L, Steinfels GF.
    Psychopharmacology (Berl); 1991 Oct 11; 105(4):447-52. PubMed ID: 1663252
    [Abstract] [Full Text] [Related]

  • 11. Nalorphine's ability to substitute for morphine in a drug discrimination procedure is a function of training dose.
    Grabus SD, Smurthwaite ST, Riley AL.
    Pharmacol Biochem Behav; 1999 Jul 11; 63(3):481-8. PubMed ID: 10418791
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological characterization of nalorphine, a kappa 3 analgesic.
    Paul D, Pick CG, Tive LA, Pasternak GW.
    J Pharmacol Exp Ther; 1991 Apr 11; 257(1):1-7. PubMed ID: 1850462
    [Abstract] [Full Text] [Related]

  • 13. Naloxone-induced analgesia: involvement of kappa-opiate receptors.
    Bianchi M, Panerai AE.
    Pharmacol Biochem Behav; 1993 Sep 11; 46(1):145-8. PubMed ID: 8255904
    [Abstract] [Full Text] [Related]

  • 14. Acute supersensitivity to the discriminative stimulus effects of naltrexone in pigeons.
    France CP, Woods JH.
    J Pharmacol Exp Ther; 1988 Feb 11; 244(2):599-605. PubMed ID: 3346837
    [Abstract] [Full Text] [Related]

  • 15. Discriminative stimulus effects of the 5HT1A agonist 8-OH-DPAT: attenuation by mu but not by kappa opioids.
    Morgan D, Picker MJ.
    Psychopharmacology (Berl); 1995 Dec 11; 122(4):336-45. PubMed ID: 8657830
    [Abstract] [Full Text] [Related]

  • 16. Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
    Negus SS, Picker MJ, Dykstra LA.
    J Pharmacol Exp Ther; 1991 Jan 11; 256(1):149-58. PubMed ID: 1846412
    [Abstract] [Full Text] [Related]

  • 17. Naloxone fails to produce conditioned place aversion in mu-opioid receptor knock-out mice.
    Skoubis PD, Matthes HW, Walwyn WM, Kieffer BL, Maidment NT.
    Neuroscience; 2001 Jan 11; 106(4):757-63. PubMed ID: 11682161
    [Abstract] [Full Text] [Related]

  • 18. Assessment of the discriminative stimulus effects of cocaine in the rat: lack of interaction with opioids.
    Broadbent J, Gaspard TM, Dworkin SI.
    Pharmacol Biochem Behav; 1995 Jan 11; 51(2-3):379-85. PubMed ID: 7667357
    [Abstract] [Full Text] [Related]

  • 19. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
    DeRossett SE, Holtzman SG.
    J Pharmacol Exp Ther; 1986 May 11; 237(2):437-44. PubMed ID: 3009783
    [Abstract] [Full Text] [Related]

  • 20. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
    Dosaka-Akita K, Tortella FC, Holaday JW, Long JB.
    J Pharmacol Exp Ther; 1993 Feb 11; 264(2):631-7. PubMed ID: 8382278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.